Virtual Reality Distraction for Pain and Anxiety in Hemodialysis Patients
ConditionPain Management
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorKarbala University
About this trial
1. Assess pain and anxiety levels in hemodialysis patients during arteriovenous fistula needle insertion. 2. Determine the effect of the distraction technique using virtual reality on pain and anxiety levels during arteriovenous fistula needle insertion in hemodialysis patients. 3. Find out the differences in the level of pain and anxiety after using virtual reality with regard to the demographic and clinical data of the sample.
Eligibility criteria
Qualifiers
Adult patients with End-Stage Renal Disease (ESRD) on hemodialysis.
Patients using a functioning arteriovenous fistula (AVF).
Conscious, oriented, and able to communicate.
Normal or corrected vision and hearing suitable for VR use.
Disqualifiers
History of motion sickness, seizures, or epilepsy.
Use of Central Venous Catheter (CVC) or Arteriovenous Graft (AVG).
Use of analgesics or sedatives within 4 hours before the procedure.
Facial wounds or eye infections preventing VR use.
Trial design
Treatments tested in this trial
- Virtual Reality
- standard of care
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Karbala University
Lead sponsor
Ministry of Health, Iraq
Sponsor institution
Source ClinicalTrials.gov